Literature DB >> 23063503

Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: a proteomics study.

Uma N M Rao1, Brian L Hood, Jacqueline M Jones-Laughner, Mai Sun, Thomas P Conrads.   

Abstract

Osteosarcomas rarely occur in older adults. Proteomics has not been reported to date in osteosarcoma occurring in the older adult population. This proteomic investigation was conducted to identify differentially expressed proteins in osteosarcoma occurring in various backgrounds from older adults. Desmoid tumors, known to recur locally but not metastasize, were also analyzed. Protein digests isolated from formalin-fixed, paraffin-embedded tumor tissue specimen representing 14 primary osteosarcomas of soft tissue and bone and 18 desmoid tumors were analyzed by high-resolution liquid chromatography-tandem mass spectrometry for protein identification and relative quantification by spectral counting. Elevated abundance levels of several proteins including heat shock protein 90 (HSP90), elastin microfibril interface-located protein 1, and clusterin were identified in osteosarcoma with slight differences in proteomic profiles. Desmoids had an abundance of collagen II and periostin only. The findings were confirmed by immunohistochemical staining for HSP90 and clusterin in the experimental samples and additionally in 16 posttherapy conventional osteosarcomas in tissue microarrays constructed from heterogeneous sarcomas and benign lesions. All osteosarcomas were positive for HSP90 and clusterin to a variable extent. One case of well-differentiated parosteal osteosarcoma was negative. Thirty of 75 other high-grade sarcomas including cases of chondrosarcoma were positive for HSP90. Low-grade and benign lesions and scars and 18 desmoid tumors had little or no expression of these proteins. HSP90 and clusterin represent candidate markers of aggressiveness in osteosarcoma occurring in older adults and may be indicative of drug resistance.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063503     DOI: 10.1016/j.humpath.2012.06.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  The crucial role of emilin 1 gene expression during progression of tumor growth.

Authors:  Miroslava Rabajdova; Peter Urban; Ivana Spakova; Ladislav Saksun; Rastislav Dudic; Alexander Ostro; Martin Caprnda; Peter Kruzliak; Mariusz Adamek; Maria Marekova
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-31       Impact factor: 4.553

Review 2.  Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes.

Authors:  Rodrigo Martins Pereira; Rania A Mekary; Kellen Cristina da Cruz Rodrigues; Chadi Pellegrini Anaruma; Eduardo Rochete Ropelle; Adelino Sanchez Ramos da Silva; Dennys Esper Cintra; José Rodrigo Pauli; Leandro Pereira de Moura
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

3.  Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors.

Authors:  Anne E Sarver; Aaron L Sarver; Venugopal Thayanithy; Subbaya Subramanian
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

4.  Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma.

Authors:  Francois Lamoureux; Marc Baud'huin; Benjamin Ory; Romain Guiho; Amina Zoubeidi; Martin Gleave; Dominique Heymann; Françoise Rédini
Journal:  Oncotarget       Date:  2014-09-15

5.  Exploring targeted therapy of osteosarcoma using proteomics data.

Authors:  Parunya Chaiyawat; Jongkolnee Settakorn; Apiruk Sangsin; Pimpisa Teeyakasem; Jeerawan Klangjorhor; Aungsumalee Soongkhaw; Dumnoensun Pruksakorn
Journal:  Onco Targets Ther       Date:  2017-02-01       Impact factor: 4.147

Review 6.  Mass Spectrometric-Based Proteomics for Biomarker Discovery in Osteosarcoma: Current Status and Future Direction.

Authors:  Nutnicha Sirikaew; Dumnoensun Pruksakorn; Parunya Chaiyawat; Somchai Chutipongtanate
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

7.  Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.

Authors:  Cemre Ucaryilmaz Metin; Gulnihal Ozcan
Journal:  BMC Cancer       Date:  2022-06-23       Impact factor: 4.638

8.  Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma.

Authors:  Dumnoensun Pruksakorn; Pimpisa Teeyakasem; Jeerawan Klangjorhor; Parunya Chaiyawat; Jongkolnee Settakorn; Penchatr Diskul-Na-Ayudthaya; Daranee Chokchaichamnankit; Peraphan Pothacharoen; Chantragan Srisomsap
Journal:  Int J Oncol       Date:  2016-07-04       Impact factor: 5.650

9.  Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network.

Authors:  Jian Chen; Xiuwen Wang; Bing Hu; Yifu He; Xiaojun Qian; Wei Wang
Journal:  PeerJ       Date:  2018-05-04       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.